Piramal Pharma Limited (NSE: PPLPHARMA)

Piramal Pharma Statistics

Total Valuation

Piramal Pharma has a market cap or net worth of INR 300.03 billion. The enterprise value is 342.12 billion.

Market Cap	300.03B
Enterprise Value	342.12B

Important Dates

The next estimated earnings date is Friday, October 25, 2024.

Earnings Date	Oct 25, 2024
Ex-Dividend Date	Jul 12, 2024

Share Statistics

Piramal Pharma has 1.33 billion shares outstanding. The number of shares has increased by 10.02% in one year.

Shares Outstanding	1.33B
Shares Change (YoY)	+10.02%
Shares Change (QoQ)	+0.59%
Owned by Insiders (%)	0.20%
Owned by Institutions (%)	27.16%
Float	607.58M

Valuation Ratios

PE Ratio	n/a
Forward PE	93.64
PS Ratio	3.53
PB Ratio	3.78
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	1,232.41
EV / Sales	4.09
EV / EBITDA	25.91
EV / EBIT	58.10
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	59.54
Debt / EBITDA	3.76
Debt / FCF	n/a
Interest Coverage	1.20

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	2.60%
Revenue Per Employee	12.46M
Profits Per Employee	41,316
Employee Count	6,719
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +118.24% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+118.24%
50-Day Moving Average	173.51
200-Day Moving Average	147.05
Relative Strength Index (RSI)	82.99
Average Volume (20 Days)	9,960,887

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Piramal Pharma had revenue of INR 83.73 billion and earned 277.60 million in profits. Earnings per share was 0.21.

Revenue	83.73B
Gross Profit	50.64B
Operating Income	5.21B
Pretax Income	2.41B
Net Income	277.60M
EBITDA	12.15B
EBIT	5.21B
Earnings Per Share (EPS)	0.21

Balance Sheet

The company has 5.02 billion in cash and 47.10 billion in debt, giving a net cash position of -42.09 billion or -31.75 per share.

Cash & Cash Equivalents	5.02B
Total Debt	47.10B
Net Cash	-42.09B
Net Cash Per Share	-31.75
Equity (Book Value)	79.11B
Book Value Per Share	59.80
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 60.48%, with operating and profit margins of 6.23% and 0.33%.

Gross Margin	60.48%
Operating Margin	6.23%
Pretax Margin	2.88%
Profit Margin	0.33%
EBITDA Margin	14.51%
EBIT Margin	6.23%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.11, which amounts to a dividend yield of 0.05%.

Dividend Per Share	0.11
Dividend Yield	0.05%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.02%
Shareholder Yield	-9.97%
Earnings Yield	0.09%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a